{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:56:54Z","timestamp":1791943014486,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.numecd.2013.05.006","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T16:00:22Z","timestamp":1375891222000},"page":"808-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients"],"prefix":"10.1016","volume":"23","author":[{"given":"L.","family":"Sciacca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tumminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Squatrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Frittitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.numecd.2013.05.006_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocrine-Related Cancer"},{"issue":"23","key":"10.1016\/j.numecd.2013.05.006_bib2","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.2008.824","article-title":"Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis","volume":"300","author":"Barone","year":"2008","journal-title":"The Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.numecd.2013.05.006_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/cas.12043","article-title":"Diabetes mellitus and cancer risk: review of the epidemiological evidence","volume":"104","author":"Shikata","year":"2013","journal-title":"Cancer Science"},{"issue":"6","key":"10.1016\/j.numecd.2013.05.006_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","article-title":"Diabetes mellitus and risk of prostate cancer: a meta-analysis","volume":"47","author":"Bonovas","year":"2004","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.numecd.2013.05.006_bib5","first-page":"233","article-title":"Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats","volume":"32","author":"Heuson","year":"1972","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.numecd.2013.05.006_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M","article-title":"ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor","volume":"18","author":"Milazzo","year":"1997","journal-title":"Molecular Carcinogenesis"},{"issue":"2","key":"10.1016\/j.numecd.2013.05.006_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/ERC-08-0240","article-title":"Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines","volume":"16","author":"Shukla","year":"2009","journal-title":"Endocrine-Related Cancer"},{"issue":"8","key":"10.1016\/j.numecd.2013.05.006_bib8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00125-010-1760-6","article-title":"Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling","volume":"53","author":"Sciacca","year":"2010","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.numecd.2013.05.006_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00125-010-1675-2","article-title":"Diabetes therapy and cancer risk: causal effects and other plausible explanations","volume":"53","author":"Hernandez-Diaz","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.numecd.2013.05.006_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.numecd.2013.05.006_bib11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.numecd.2012.10.004","article-title":"Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? an open debate on the ORIGIN study results","volume":"22","author":"Bolli","year":"2012","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases: NMCD"},{"issue":"18","key":"10.1016\/j.numecd.2013.05.006_bib12","first-page":"3","article-title":"Basal insulin and cardiovascular and other outcomes","volume":"367","author":"Vigneri","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.numecd.2013.05.006_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jc.2012-3042","article-title":"Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes","volume":"98","author":"Currie","year":"2013","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.numecd.2013.05.006_bib14","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-1432","article-title":"Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among U.S. Adults with diagnosed diabetes: findings from the 2009 behavioral risk factor surveillance system","author":"Li","year":"2013","journal-title":"Diabetes Care"},{"issue":"7431","key":"10.1016\/j.numecd.2013.05.006_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11781","article-title":"How insulin engages its primary binding site on the insulin receptor","volume":"493","author":"Menting","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.numecd.2013.05.006_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI114868","article-title":"Elevated insulin receptor content in human breast cancer","volume":"86","author":"Papa","year":"1990","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.numecd.2013.05.006_bib18","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells","volume":"19","author":"Frasca","year":"1999","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"10.1016\/j.numecd.2013.05.006_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.onc.1210660","article-title":"Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha","volume":"27","author":"Cascio","year":"2008","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.cellsig.2010.05.003","article-title":"Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB\/HIF-1alpha activation","volume":"22","author":"Gonzalez-Perez","year":"2010","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/dc06-0922","article-title":"Prospective study of hyperglycemia and cancer risk","volume":"30","author":"Stattin","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2013.05.006_bib22","article-title":"High glycemic diet and breast cancer occurrence in the Italian EPIC cohort","author":"Sieri","year":"2012","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib23","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-010-1796-7","article-title":"Diabetes, prediabetes and cancer mortality","volume":"53","author":"Zhou","year":"2010","journal-title":"Diabetologia"},{"issue":"5930","key":"10.1016\/j.numecd.2013.05.006_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.numecd.2013.05.006_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr1852","article-title":"Sugar and fat - that's where it's at: metabolic changes in tumors","volume":"10","author":"Young","year":"2008","journal-title":"Breast Cancer Research"},{"issue":"7","key":"10.1016\/j.numecd.2013.05.006_bib26","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-activated protein kinase signaling in metabolic regulation","volume":"116","author":"Long","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.numecd.2013.05.006_bib27","doi-asserted-by":"crossref","first-page":"e005967","DOI":"10.1161\/JAHA.112.005967","article-title":"Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia","volume":"1","author":"Bhattacharyya","year":"2012","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/carcin\/bgp322","article-title":"Fueling inflammation at tumor microenvironment: the role of multiligand\/RAGE axis","volume":"31","author":"Rojas","year":"2010","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib29","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.numecd.2013.05.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2005.10.013","article-title":"Obesity and cancer","volume":"16","author":"Vigneri","year":"2006","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"17","key":"10.1016\/j.numecd.2013.05.006_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"16","key":"10.1016\/j.numecd.2013.05.006_bib32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.numecd.2013.05.006_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcp.20472","article-title":"Leptin and cancer","volume":"207","author":"Garofalo","year":"2006","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"10.1016\/j.numecd.2013.05.006_bib34","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/0008-5472.CAN-11-2558","article-title":"Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells","volume":"72","author":"Barone","year":"2012","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.numecd.2013.05.006_bib35","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00125-012-2629-7","article-title":"Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in\u00a0vitro","volume":"55","author":"D'Esposito","year":"2012","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.numecd.2013.05.006_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/138161207780249182","article-title":"Crosstalk between IGF signaling and steroid hormone receptors in breast cancer","volume":"13","author":"Sisci","year":"2007","journal-title":"Current Pharmaceutical Design"},{"issue":"20","key":"10.1016\/j.numecd.2013.05.006_bib37","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.4161\/cc.8.20.9699","article-title":"Inflammation: a driving force speeds cancer metastasis","volume":"8","author":"Wu","year":"2009","journal-title":"Cell Cycle"},{"issue":"7203","key":"10.1016\/j.numecd.2013.05.006_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"7007","key":"10.1016\/j.numecd.2013.05.006_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib41","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.numecd.2013.05.006_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1463-1326.2005.00567.x","article-title":"Novel insulin analogues and its mitogenic potential","volume":"8","author":"Zib","year":"2006","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib43","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00125-009-1441-5","article-title":"Does diabetes therapy influence the risk of cancer?","volume":"52","author":"Smith","year":"2009","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.diabet.2006.12.002","article-title":"Glargine blood biotransformation: in\u00a0vitro appraisal with human insulin immunoassay","volume":"33","author":"Agin","year":"2007","journal-title":"Diabetes & Metabolism"},{"issue":"6","key":"10.1016\/j.numecd.2013.05.006_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dmrr.736","article-title":"Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality","volume":"23","author":"Monami","year":"2007","journal-title":"Diabetes Metabolism Research and Reviews"},{"key":"10.1016\/j.numecd.2013.05.006_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(13)60061-X","article-title":"Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis","author":"Singh","year":"2013","journal-title":"The American Journal of Gastroenterology"},{"issue":"5","key":"10.1016\/j.numecd.2013.05.006_bib47","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1530\/ERC-12-0111","article-title":"GLP1 and cancer: friend or foe?","volume":"19","author":"Vangoitsenhoven","year":"2012","journal-title":"Endocrine-Related Cancer"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejim.2013.01.009","article-title":"Incretin-based therapies in the treatment of type 2 diabetes\u2013more than meets the eye?","volume":"24","author":"Labuzek","year":"2013","journal-title":"European Journal of Internal Medicine"},{"issue":"2","key":"10.1016\/j.numecd.2013.05.006_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16","volume":"33","author":"Landman","year":"2010","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.numecd.2013.05.006_bib50","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.numecd.2013.05.006_bib51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/fon.11.49","article-title":"Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer","volume":"7","author":"Guppy","year":"2011","journal-title":"Future Oncology"},{"issue":"2","key":"10.1016\/j.numecd.2013.05.006_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1634\/theoncologist.2012-0302","article-title":"Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis","volume":"18","author":"Bosetti","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.numecd.2013.05.006_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/dme.12144","article-title":"Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies","author":"Ferwana","year":"2013","journal-title":"Diabet Medicine"},{"issue":"4","key":"10.1016\/j.numecd.2013.05.006_bib54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/193229681200600417","article-title":"Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus","volume":"6","author":"Reilly","year":"2012","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"34","key":"10.1016\/j.numecd.2013.05.006_bib55","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.3748\/wjg.14.5282","article-title":"Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project)","volume":"14","author":"Festi","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W","article-title":"Risk of endometrial and breast cancer in patients with diabetes mellitus","volume":"71","author":"Weiderpass","year":"1997","journal-title":"International Journal of Cancer Journal International du Cancer"},{"issue":"3","key":"10.1016\/j.numecd.2013.05.006_bib57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/IGC.0b013e31828189b2","article-title":"Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies","volume":"23","author":"Lee","year":"2013","journal-title":"International Journal of Gynecological Cancer"},{"issue":"10","key":"10.1016\/j.numecd.2013.05.006_bib58","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1055-9965.EPI-12-0771","article-title":"Insulin therapy and colorectal adenomas in patients with diabetes mellitus","volume":"21","author":"Wong","year":"2012","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.numecd.2013.05.006_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2013.01.004","article-title":"Diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis","author":"Bao","year":"2013","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib60","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ijc.27878","article-title":"Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study","volume":"132","author":"Newton","year":"2013","journal-title":"International Journal of Cancer Journal International du Cancer"},{"issue":"7","key":"10.1016\/j.numecd.2013.05.006_bib61","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"The Lancet Oncology"},{"issue":"10","key":"10.1016\/j.numecd.2013.05.006_bib62","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00125-008-1114-9","article-title":"A genetic link between type 2 diabetes and prostate cancer","volume":"51","author":"Frayling","year":"2008","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.numecd.2013.05.006_bib63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Emerging Risk Factors C","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.numecd.2013.05.006_bib64","doi-asserted-by":"crossref","DOI":"10.1089\/pop.2012.0020","article-title":"Reducing the risks of diabetes complications through diabetes self-management education and support","author":"Kent","year":"2013","journal-title":"Population Health Management"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T14:39:28Z","timestamp":1563633568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475313001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0939475313001348"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2013.05.006","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2013.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}